30 closest matches · ranked by relevance
Living Donors · Nephrectomy · Kidney Transplantation
Primary: The Primary End Point of the Study Was the Mean/Median Number of Days Postsurgery Required for Each Group to Return to 100% Functioning Capacity. — 43; 45 days
Kidney Transplant
Primary: Percent of Patients With at Least One Inquiry From a Potential Living Donor — 15.63; 15.63; 15.77; 15.87 percentage of participants
Kidney Disease
Primary: Number of Participants With Live Kidney Donor Activation Events — 87; 86; 88; 5 Participants
End-stage Renal Disease · Chronic Kidney Diseases
Primary: Living Donor Inquiry — 16.0; 18.6 Percentage of participants — p=0.507
Renal Transplant Rejection · Transplants and Implants
Primary: Composite End Point of Acute Rejection, Graft Loss or Patient Death — 1; 1; 0; 0 participants
Kidney Transplant
Primary: Number of Subjects With Antibody-Mediated Rejection (AMR) in the First 3 Months After Living Donor Kidney Transplantation — 2 Participants
End Stage Renal Disease
Primary: Number of Steps Completed in Transplant Process — 1.0; 2.8 steps per participant
Kidney Transplantation · Kidney Failure, Chronic
Primary: Number of Participants Successfully Withdrawn Off of Immunosuppressant Medication for 104 Weeks — 3 participants
Kidney Diseases · Kidney Failure, Chronic · Kidney Failure
Primary: Plasma Creatine Concentration of the Recipients — 849.5; 878.5; 771.0; 776.5 μmol/l
Liver Transplantation
Primary: Number of Participants With Composite Efficacy Failure of Treated Biopsy Proven Acute Rejection, Graft Loss or Death in Everolimus With Reduced Tacrolimus Group Compared…
End Stage Renal Disease
Primary: Number of Subjects Cured — 62 Participants
Renal Failure
Primary: Number of Participants With Undetectable HCV RNA at SVR12 — 8 Participants
End Stage Renal Disease
Primary: Successful Withdrawal of Immunosuppressive Therapy — 2 Participants
Immunosuppression · Kidney Transplantation · Graft Rejection
Primary: The Ability to Withdraw Immunosuppression as Above 24 Months Post-transplant — 6 Participants
Kidney Transplant
Primary: Percentage of Correct Answers on Knowledge of Kidney Transplant Options Assessment — 6; 14; 2; 1 Participants
Renal Failure Chronic · Hepatitis C
Primary: Number of Participants With Undetectable HCV — 30 Participants
Renal Cell Carcinoma · Graft-Versus-Host Disease · Engraftment Syndrome
Primary: Clinical Regression of Metastatic Renal Cell Carcinoma (Partial Response (PR)) or Complete Remission of Tumor (Complete Response (CR)) — 0; 0; 8; 1 participants
Renal Transplant Donor of Left Kidney · Donor Nephrectomy · Robotic Surgery
Primary: Successful Completion of the Surgical Procedure — 3 Participants
Skin Closure of Surgical Incisions by Tissue Glue vs Suture
Primary: Wound Healing by Numerical Scales for Rubor Postoperative Day 2. — 0.516; 0.984 units on a scale
Kidney Failure, Chronic
Primary: 6-month Acute Cellular-mediated Rejection Rate (CMR) — 14; 20 Participants
Kidney Failure, Chronic · Renal Insufficiency
Primary: Number of Participants With Successful Withdrawal of Immunosuppression — 2 Participants
End Stage Renal Disease · Hepatitis C
Primary: Viral Response as Assessed by Number of Participants With Undetectable Hepatitis C RNA — 10 Participants
Diabetes Mellitus, Type I
Primary: Insulin Independence With Both an HbA1c ≤ 6.5% and no Severe Hypoglycemic Events at 1 Year After the First Islet Transplant or a Reduction in HbA1c of at Least 1 Point…
Kidney Transplantation · Kidney Disease · Kidney Failure
Primary: Overall Participant Survival at One Year Post Kidney Transplant — 4; 5 participants
Kidney Failure
Primary: Serum Creatinine Concentration — 112 umol/L
Kidney Transplantation
Primary: The Rate of Allograft Rejection — 0; 0 participants
End Stage Renal Disease (ESRD)
Primary: Number of Participants With Serious Infectious Complications Following Transplantation — 2 participants
Living Donor Liver Transplantation
Primary: Proportion of Safety Events — 1 Participants
Utilization, Health Care · Obesity
Primary: Emergency Department Utilization — 77; 305 Participants
End Stage Renal Disease · Hepatitis C
Primary: Viral Response at Week 12 — 10 Participants